Latest Whitepapers

Many regulatory guidelines state that cell banks and cultures used in the production of biologics must be tested for mycoplasma. Mycoplasma infections can cause severe problems in manufacturing as these organisms can alter DNA, RNA and modify host cell plasma membrane antigens.

Serious infectious disease outbreaks have been an ever-present threat throughout human history and, driven by factors such as increasing globalization, population growth, urbanization and climate change, that threat is increasing.

GeoMx® Human Whole Transcriptome Atlas

Traditional gene expression technologies are unable to capture heterogeneity of the transcriptome with spatial context.

Spatially resolved biology allows researchers to study cells in the context of their tissue microenvironment, enabling a fuller appreciation of cellular function.

While next-generation sequencing is becoming increasingly routine in cancer research laboratories, it fails to address a number of key genomic drivers or markers of cancer, such as structural variations, DNA methylation and transcript isoforms.

Download this whitepaper to discover how CRISPR can overcome antibiotic-resistant and pathogenic bacteria.

Download this whitepaper to discover how the manufacturing process was successfully scaled using operational support, a customized solution as well as a highly collaborative and strategic engagement.

The global cosmetics industry is worth more than $500 billion, but relies on ingredients that are unsustainable and cause harm to plant and animal life. Growing awareness of this problem among consumers has fueled a demand for something different.

Primary antibody labeling simplifies assays, enables multiplexing and eliminates the cross-reactivity seen with secondary antibodies – helping you to streamline your workflow, increase your flexibility and improve reproducibility.

Creating and bringing new drugs to the market can bring huge productivity challenges as the already complex drug development process becomes lengthier and more expensive.